FDA approval of Orca Bio’s Tregzi makes it the first cell therapy based on regulatory T cells, or Tregs. Clinical trial results showed reduced risk of graft-versus-host disease, a common complication of the allogeneic stem cell transplants that are a standard treatment for certain blood cancers.
The post Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living Medicine appeared first on MedCity News.
Malicious browser extension targets cryptocurrency users with wallet address swapping – SC Media
Malicious browser extension targets cryptocurrency users with wallet address swapping SC Media
